Asthma & allergies

We’re allergic to bad Indoor Air Quality.

How long do you spend inside? You might be surprised to learn that, on average, we spend 90% of our life indoors*. It’s why the quality of the air we breathe inside is such a major factor in our health and wellbeing. However, global trends show that people who suffer from allergies and asthma is on the increase**. 14% of children worldwide are now affected by asthma and it has become a major cause of school absenteeism***.

Good air quality can make a difference. In fact, it has even been proven to impact office productivity levels by improving the ability to concentrate and process information. Studies show a productivity increase of up to 5% when air quality improves****. At Tarkett, we know that the floor covering you choose is linked to the quality of the indoor air you breathe. That’s a responsibility we take very seriously and for decades we have championed the importance of products that offer the best indoor air quality possible.

We’re leading the way in designing products that promote comfortable, healthy environments. For example, our Desso AirMaster carpets capture the invisible dust particles in the air and prevent them from becoming airborne again until they can be vacuumed away. Allergy UK has also given us their seal of approval for our vinyl and linoleum flooring with exceptionally low volatile organic compounds (VOC) emission levels. Levels so low, they are unquantifiable.

For us ‘good enough’ is never good enough. We’re committed to continually beating our own industry-leading high standards. We’re also committed to complete transparency in terms of the selection and independent testing of every last component of our products. It means that when you select a Tarkett flooring, you can trust the science, and trust that you have a quality product that puts your health first.

Making conscious choices. For people and planet.
Tarkett Human-Conscious Design^TM.

* US Environmental Protection Agency, 1989. Report to Congress on indoor air quality: Volume 2. EPA/400/1-89/001C. Washington, DC
**The rising trends in asthma and allergic disease. Clin Exp Allergy. 1998;28(Suppl 5):45-49. discussion 50-1, E. von Mutius
***Forum of International Respiratory Societies – FIRS
**** William J. Fisk and Arthur H. Rosenfeld of the Lawrence Berkeley National Laboratory in Berkeley in California, US